TCI : The Company's shareholders' meeting approved the release of shares of TCI Gene Inc. and the waiver of participation in its cash capital increase plan
The Company's shareholders' meeting approved the
release of shares of TCI Gene Inc. and the waiver of
participation in its cash capital increase plan
Date of events
2022/06/29
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/06/29
2.Company name:TCI Co., Ltd.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:Not applicable
5.Cause of occurrence:In line with the announcement of the
regulations related to the underwriting of the initial
listing of the new shares of our subsidiary, TCI Gene Inc.
6.Countermeasures:
Approved by the shareholders' meeting and announced
on the Market Observation Post System
7.Any other matters that need to be specified:
The above-mentioned matters related to the release of
shares and/or the waiver of cash subscriptions of the
planned listed subsidiary were proposed to the
shareholders' meeting to authorize the board of
directors to handle the related matters.
Attachments
Original Link
Original Document
Permalink
Disclaimer
TCI Co. Ltd. published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 13:48:10 UTC.
TCI Co Ltd is a Taiwan-based company principally engaged in the research, development, manufacture and sale of functional beverages, health foods and beauty care products. The health food includes various types of food, such as hard capsules, soft capsules, pastilles, powder, liquid packs, jelly and oil-based hard gelatine. The beauty care products include facial and body care products, such as facial masks, eye masks, facial cleansers, anti-acne gel, whitening cream, slimming cream, breast enhancement cream and serum. In addition, the Company is engaged in the production and sale of biological products, various medical devices and confidential chemical materials. The Company distributes its products in domestic market and to overseas markets.
TCI : The Company's shareholders' meeting approved the release of shares of TCI Gene Inc. and the waiver of participation in its cash capital increase plan